Skip to main content
OpenTrials

Clinical trial condition

Leukemia, B-Cell

Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.

1,388 public trials 159 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, B-Cell trial results

Completed

Observatory of Patients With Chronic Lymphocytic Leukemia / Lymphocytic Lymphoma or Waldenstrom Disease Infected With COVID-19

NCT04391946

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma or Waldenstrom Disease, Disease Attributes, +14 more
Locations
  • Chu Angers Angers, France
  • CHU Jean Minjoz - Hématologie Besançon, France
  • Hôpital Avicenne - Centre de Recherche Clinique Bobigny, France
  • CHU Estaing - Hématologie Clinique Adulte Clermont-Ferrand, France
View all 22 locations
View Trial Details
Completed

Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia

NCT00602459

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +17 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • PCR Oncology Arroyo Grande, California, United States
  • Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States
  • Palo Alto Medical Foundation-Camino Division Mountain View, California, United States
View all 364 locations
View Trial Details
Completed

Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT01027000

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States
  • CCOP - Christiana Care Health Services Newark, Delaware, United States
  • Florida Hospital Cancer Institute at Florida Hospital Orlando Orlando, Florida, United States
View all 25 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy of Venetoclax Monotherapy in Relapsed/Refractory Participants With Chronic Lymphocytic Leukemia (CLL)

NCT02756611

Conditions
Chromosome 17 deletion, Chronic Disease, Chronic Lymphocytic Leukemia, +16 more
Locations
  • Norton Cancer Institute /ID# 149788 Louisville, Kentucky, United States
  • St. Agnes Cancer Center /ID# 149782 Baltimore, Maryland, United States
  • Hackensack Univ Med Ctr /ID# 151574 Hackensack, New Jersey, United States
  • Utah Cancer Specialists /ID# 151604 Salt Lake City, Utah, United States
View all 67 locations
View Trial Details
Completed

Study to Describe the Management and the Use of Healthcare Resources in Patients With Chronic Lymphocytic Leukemia (CLL) Initiating Venetoclax in Routine Clinical Practice

NCT03310190

Conditions
Chromosome 17 deletion, Chronic Disease, Chronic Lymphocytic Leukemia, +15 more
Locations
  • University of Calgary /ID# 166416 Calgary, Alberta, Canada
  • Cross Cancer Institute /ID# 166417 Edmonton, Alberta, Canada
  • Jack Ady Cancer Centre /ID# 217491 Lethbridge, Alberta, Canada
  • CancerCare Manitoba /ID# 170751 Winnipeg, Manitoba, Canada
View all 13 locations
View Trial Details
Completed

A Study to Evaluate the Safety, Tolerability, and Efficacy of Relatlimab in Relapsed or Refractory B-Cell Malignancies

NCT02061761

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • Local Institution - 0007 Baltimore, Maryland, United States
  • Local Institution - 0004 Boston, Massachusetts, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Local Institution - 0010 St Louis, Missouri, United States
View Trial Details

Related conditions